Nextech leads a $56M round for the Revolution's move into the clinic

Retrieved on: 2018-04-23 18:18:45

Tags for this article:

Click the tags to see associated articles and topics

Nextech leads a $56M round for the Revolution's move into the clinic. View article details on hiswai:

Excerpt

<div>... and Barbara Weber, chief executive officer of Tango Therapeutics, joined the company's board of directors. Nextech Invest, an oncology-focused investment firm, led the round with participation from Casdin Capital, Schroder Adveq, The Column Group, <b>Third Rock Ventures</b> and “additional undisclosed ...</div>

Article found on:

View Original Article